194 related articles for article (PubMed ID: 32536821)
1. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer.
Sun ZG; Pan F; Shao JB; Yan QQ; Lu L; Zhang N
Cancer Cell Int; 2020; 20():233. PubMed ID: 32536821
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
3. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
5. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanism of kinesin family member 2A (KIF2A) underlying non-small cell lung cancer: the effect of its knockdown on malignant behaviors, stemness, chemosensitivity, and potential regulated signaling pathways.
Chen J; Wen J; Liu D; Xu X; Fan M; Zhang Z
Am J Transl Res; 2022; 14(1):68-85. PubMed ID: 35173830
[TBL] [Abstract][Full Text] [Related]
7. LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis.
Liu X; Niu N; Li P; Zhai L; Xiao K; Chen W; Zhuang X
Cancer Cell Int; 2021 Aug; 21(1):425. PubMed ID: 34389018
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
10. RPB5-mediating protein promotes the progression of non-small cell lung cancer by regulating the proliferation and invasion.
Feng Y; Chen K; Pan L; Jiang W; Pang P; Mao G; Zhang B; Chen S
J Thorac Dis; 2021 Jan; 13(1):299-311. PubMed ID: 33569210
[TBL] [Abstract][Full Text] [Related]
11. Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells.
Jing X; Du L; Niu A; Wang Y; Wang Y; Wang C
Biomed Res Int; 2020; 2020():1276328. PubMed ID: 32337219
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LncRNAZFAS1 suppresses cell proliferation and metastasis in non-small cell lung cancer.
Zhou Y; Hu XW; Yang SJ; Yu Z
Anim Cells Syst (Seoul); 2020; 24(2):107-113. PubMed ID: 32489690
[TBL] [Abstract][Full Text] [Related]
14. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
16. Green tea-derived theabrownin suppresses human non-small cell lung carcinoma in xenograft model through activation of not only p53 signaling but also MAPK/JNK signaling pathway.
Xiao X; Guo L; Dai W; Yan B; Zhang J; Yuan Q; Zhou L; Shan L; Efferth T
J Ethnopharmacol; 2022 Jun; 291():115167. PubMed ID: 35271947
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of USP8 Inhibits the Growth of Lung Cancer Cells.
Rong Z; Zhu Z; Cai S; Zhang B
Cancer Manag Res; 2020; 12():12415-12422. PubMed ID: 33293867
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
20. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
